Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | APEX nuclease (multifunctional DNA repair enzyme) 1 | Starlite/ChEMBL | No references |
Homo sapiens | arachidonate 15-lipoxygenase, type B | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | lipoxygenase | 0.0142 | 0.3076 | 0.3076 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0209 | 0.4811 | 0.5 |
Leishmania major | monoglyceride lipase, putative | 0.0209 | 0.4811 | 1 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0409 | 1 | 1 |
Schistosoma mansoni | amidase | 0.0409 | 1 | 1 |
Plasmodium falciparum | lysophospholipase, putative | 0.0209 | 0.4811 | 1 |
Echinococcus granulosus | glutamyl tRNAGln amidotransferase subunit A | 0.0049 | 0.0663 | 0.0663 |
Wolbachia endosymbiont of Brugia malayi | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0049 | 0.0663 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0209 | 0.4811 | 0.5 |
Mycobacterium ulcerans | lysophospholipase | 0.0209 | 0.4811 | 1 |
Mycobacterium leprae | POSSIBLE LYSOPHOSPHOLIPASE | 0.0209 | 0.4811 | 1 |
Plasmodium falciparum | lysophospholipase, putative | 0.0209 | 0.4811 | 1 |
Plasmodium falciparum | glutamyl-tRNA(Gln) amidotransferase subunit A | 0.0049 | 0.0663 | 0.1379 |
Trypanosoma cruzi | monoglyceride lipase, putative | 0.0209 | 0.4811 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0209 | 0.4811 | 0.5 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0409 | 1 | 1 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0209 | 0.4811 | 0.5 |
Onchocerca volvulus | 0.0024 | 0 | 0.5 | |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0209 | 0.4811 | 0.5 |
Plasmodium vivax | glutamyl-tRNA(Gln) amidotransferase subunit A, putative | 0.0049 | 0.0663 | 0.1379 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0049 | 0.0663 | 0.0663 |
Plasmodium falciparum | esterase, putative | 0.0209 | 0.4811 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0209 | 0.4811 | 1 |
Plasmodium falciparum | lysophospholipase, putative | 0.0209 | 0.4811 | 1 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0209 | 0.4811 | 1 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0209 | 0.4811 | 0.5 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0142 | 0.3076 | 0.3076 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0209 | 0.4811 | 1 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0409 | 1 | 1 |
Plasmodium vivax | PST-A protein | 0.0209 | 0.4811 | 1 |
Treponema pallidum | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0049 | 0.0663 | 0.5 |
Schistosoma mansoni | fatty-acid amide hydrolase | 0.0409 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0209 | 0.4811 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0209 | 0.4811 | 0.5 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0142 | 0.3076 | 0.3076 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0049 | 0.0663 | 0.0663 |
Schistosoma mansoni | glutamyl-tRNA(Gln) amidotransferase subunit A | 0.0049 | 0.0663 | 0.0663 |
Loa Loa (eye worm) | hypothetical protein | 0.0409 | 1 | 1 |
Brugia malayi | Amidase family protein | 0.0049 | 0.0663 | 0.0663 |
Schistosoma mansoni | lipoxygenase | 0.01 | 0.1964 | 0.1964 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0209 | 0.4811 | 0.5 |
Chlamydia trachomatis | glutamyl-tRNA(Gln) amidotransferase subunit A | 0.0049 | 0.0663 | 0.5 |
Echinococcus multilocularis | glutamyl tRNA(Gln) amidotransferase subunit A | 0.0049 | 0.0663 | 0.0663 |
Schistosoma mansoni | fatty-acid amide hydrolase | 0.0049 | 0.0663 | 0.0663 |
Onchocerca volvulus | 0.0024 | 0 | 0.5 | |
Mycobacterium tuberculosis | Possible lysophospholipase | 0.0209 | 0.4811 | 1 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0409 | 1 | 1 |
Loa Loa (eye worm) | amidase | 0.0049 | 0.0663 | 0.0663 |
Loa Loa (eye worm) | amidase | 0.0049 | 0.0663 | 0.0663 |
Trichomonas vaginalis | valacyclovir hydrolase, putative | 0.0209 | 0.4811 | 0.5 |
Brugia malayi | putative amidase | 0.0049 | 0.0663 | 0.0663 |
Brugia malayi | Amidase family protein | 0.0049 | 0.0663 | 0.0663 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 2.9081 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 3.6964 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 7.0795 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 19.9526 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2312, AID2537, AID2702] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.